World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
14710
World Ranking
3128
National Ranking
137

Pierre Galanaud publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Pierre Galanaud sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 235 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Pierre Galanaud D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Pierre Galanaud sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Pierre Galanaud is affiliated with the University of Paris-Saclay in France. Their research primarily lies within the field of Medicine with a focus on several intersecting subfields including Infectious Diseases, Neurology, Genetics, Sociology and Political Science, and Economics and Econometrics.

Their recent scholarly work covers a range of topics centered mainly on infectious diseases such as COVID-19 and historical epidemiology. The key topics addressed in their research include:

  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research
  • Yersinia bacterium, plague, ectoparasites research
  • Vietnamese History and Culture Studies
  • Historical Economic and Social Studies

Pierre Galanaud has contributed to publications in various reputable venues, including:

  • Clinical Immunology
  • PLoS ONE
  • Science

Their notable recent papers include:

  • "A plea for the pathogenic role of immune complexes in severe Covid-19" (2020) published in Clinical Immunology
  • "Mortality and demographic recovery in early post-black death epidemics: Role of recent emigrants in medieval Dijon" (2020) published in PLoS ONE
  • "Recent immigrants at increased pandemic risk" (2020) published in Science

Collaboration is a part of their research activity, with frequent co-authors comprising Anne Galanaud, Dominique A. Vuitton, Lucine Vuitton, Estelle Seillès, and Patrick Giraudoux. These collaborations have contributed to cross-disciplinary insights within their fields of study.

Best Publications

  • Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

    M Humbert;G Monti;F Brenot;O Sitbon

  • Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells.

    Weiping Zou;Weiping Zou;Véronique Machelon;Aurore Coulomb-L'Hermin;Jozef Borvak

  • Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.

    Luis Llorente;Weiping Zou;Yves Levy;Yvonne Richaud-Patin

  • Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus

    Luis Llorente;Yvonne Richaud-Patin;Carlos García-Padilla;Emmanuel Claret

  • In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity.

    Luis Llorente;Yvonne Richaud‐Patin;Renato Fior;Jorge Alcocer‐Varela

  • Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13.

    A Marfaing-Koka;O Devergne;G Gorgone;A Portier

  • Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients.

    M Humbert;G Monti;M Fartoukh;A Magnan

  • Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes.

    D Emilie;M Peuchmaur;M C Maillot;M C Crevon

  • Interleukin-6 gene expression in Castleman's disease.

    MB Leger-Ravet;M Peuchmaur;O Devergne;J Audouin

  • Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis

    Francois G. Brivet;Dominique Emilie;Pierre Galanaud

  • In vitro production of IL-6, IL-1 beta, and tumor necrosis factor-alpha by human embryonic microglial and neural cells.

    G Sébire;D Emilie;C Wallon;C Héry

  • Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus.

    L Llorente;Y Richaud-Patin;J Wijdenes;J Alcocer-Varela

  • Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3α/CCL20 in human B cells

    Roman Krzysiek;Eric A. Lefevre;Eric A. Lefevre;Jérôme Bernard;Jérôme Bernard;Arnaud Foussat;Arnaud Foussat

  • Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human.

    Arnaud Foussat;Aurore Coulomb-L'Hermine;Jennifa Gosling;Roman Krzysiek

  • Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus

    Luis Llorente;Yvonne Richaud-Patin;Jacques Couderc;Donato Alarcon-Segovia

  • Suppressor cell function after intravenous gammaglobulin treatment in adult chronic idiopathic thrombocytopenic purpura.

    J F Delfraissy;G Tchernia;Y Laurian;C Wallon

  • GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response

    Nicolas Cohen;Nicolas Cohen;Enguerran Mouly;Enguerran Mouly;Haifa Hamdi;Haifa Hamdi;Marie-Christine Maillot;Marie-Christine Maillot

  • Macrophage-Derived Dendritic Cells Have Strong Th1-Polarizing Potential Mediated by β-Chemokines Rather Than IL-12

    Weiping Zou;Jozef Borvak;Florentina Marches;Shuang Wei

  • Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells.

    Roman Krzysiek;Eric A. Lefèvre;Weiping Zou;Arnaud Foussat

  • Role of the Chemokine Stromal Cell-Derived Factor 1 in Autoantibody Production and Nephritis in Murine Lupus

    Karl Balabanian;Jacques Couderc;Laurence Bouchet-Delbos;Ali Amara

  • SYNTHESIS OF GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (GILZ) BY MACROPHAGES: AN ANTI-INFLAMMATORY AND IMMUNOSUPPRESSIVE MECHANISM SHARED BY GLUCOCORTICOIDS AND IL-10 Running title: Glucocorticoids, IL-10 and GILZ

    Dominique Emilie Bouchet-Delbos;Marie-Christine Maillot;Alain Portier;Jacques Couderc

Frequent Co-Authors

Jean-François Delfraissy
Jean-François Delfraissy National Ethical Consultative Committee for Life Sciences and Health
Marc Humbert
Marc Humbert University of Paris-Saclay
Sonia Berrih-Aknin
Sonia Berrih-Aknin Université Paris Cité
John Wijdenes
John Wijdenes Grenoble Alpes University
Luis Llorente
Luis Llorente Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
François Boué
François Boué University of Paris-Saclay
Gérald Simonneau
Gérald Simonneau University of Paris-Saclay
Jean-François Bach
Jean-François Bach Grenoble Alpes University
Ali Amara
Ali Amara Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related fields such as nursing can open additional career opportunities. Accelerated programs allow students to fast-track their education and enter the workforce sooner. For instance, accelerated np programs online help registered nurses advance to nurse practitioner roles with a focus on patient care, often involving immunological knowledge.

Students without a nursing background can still pursue this path through online rn programs for non nurses. These programs are designed to accommodate those switching careers and provide foundational nursing education remotely, making them accessible to a wider audience.

For quicker entry into nursing, many consider the easiest absn programs to get into. These accelerated Bachelor of Science in Nursing programs typically offer streamlined admissions and intensive coursework to prepare students for the nursing profession rapidly.

Alternatively, becoming a Licensed Practical Nurse (LPN) is a practical step for gaining hands-on experience in healthcare settings. Accredited LPN programs with less competitive admissions, like those listed under accredited lpn programs easy to get into, allow students to begin their nursing careers swiftly and effectively.

Best Scientists Citing Pierre Galanaud

Trending Scientists

Recently Published Articles